Bio Path | Spese Operative



Operating Expenses Cambiamento Data
Baxter International USD 3.19B 644M 2024-12
Cipla INR 55.01B 1.37B 2025-03
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 8.95M 3.68M 2024-12
CSL USD 5.72B 173M 2024-12
Grifols EUR 1.6B 128.03M 2024-12


Bio Path Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.